The majority of rare diseases are chronic disorders which are most often of genetic origin (in 80% of the cases) and mainly affect children (60%). Each disease is rare (1/2000 person), but together the rare disorders affect around 6-8% of the general population.
The number of people suffering from rare diseases is estimated to be around 3 million in France, 50 million in the Mediterranean Basin, 25 to 30 million in Europe and 27 million in North America. But Less than 5 % of patients receive an adapted treatment!
A new healthcare model > GIPTIS (Genetics Institute for Patients, Therapies, Innovation and Science)
GIPTIS reinvents healthcare’s organizational model by placing patients affected with rare disease at the heart of a care and research loop to accelerate drug development, using an unprecedented public-private cooperation. The 3 main goals are:
• Reduce diagnostic wavering
• Improve global patient care
• Reduce the drug development period to less than 10 years
GIPTIS will gather in an unique place at the cutting edge of technology: private companies deeply associated to research projects, international & high potential researchers, healthcare professionals, technological resources centers, in-house support and drug development
departments.
The covered expertises will be:
• From developmental biology to genetics of rare diseases
• From epigenetics to genomes dynamics
• From bioinformatics to system and integrative biology
Company Details
- Founded
- -
- Address
- 61, Boulevard Des Dames, Marseille,provence-Alpes-Côte D’azur 13002,france
- Industry
- Think Tanks
- NAICS
-
Research and Development in the Social Sciences and Humanities
- Website
- giptis.com
- Keywords
- génétique and maladies rares.
- HQ
- Marseille, Provence-Alpes-Côte d’Azur
- Competitors
- Rare Ireland, Epiontis GmbH (now Precision for Medicine), CLOSE YOUR EYES, Pachyonychia Congenita Project (PC Project), OrphanDev, The Sturge-Weber Foundation, NUES Inc. (SBA 8a Certified Firm and WOSB), The Orphan Disease Collective, Cure & Action for Tay-Sachs (CATS) Foundation, Lysosomal Storage Disorders Support Society (LSDSS) - India.
Giptis (Genetics Institute For Patients, Therapies, Innovation & Science) Questions
Giptis (Genetics Institute For Patients, Therapies, Innovation & Science)'s website is giptis.com
Giptis (Genetics Institute For Patients, Therapies, Innovation & Science)'s LinkedIn profile is https://fr.linkedin.com/company/giptis
Giptis (Genetics Institute For Patients, Therapies, Innovation & Science)'s industry is
Think Tanks
Giptis (Genetics Institute For Patients, Therapies, Innovation & Science)'s top competitors are
Rare Ireland,
Epiontis Gmbh (Now Precision For Medicine),
Close Your Eyes,
Pachyonychia Congenita Project (Pc Project),
Orphandev,
The Sturge-Weber Foundation,
Nues Inc. (Sba 8a Certified Firm And Wosb),
The Orphan Disease Collective,
Cure & Action For Tay-Sachs (Cats) Foundation,
Lysosomal Storage Disorders Support Society (Lsdss) - India.
Giptis (Genetics Institute For Patients, Therapies, Innovation & Science)'s categories are Think Tanks
Giptis (Genetics Institute For Patients, Therapies, Innovation & Science)'s founding year is 2017
